Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Ambria Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 8
Average round size
info
The average size of a deal this fund participated in
$9M
Portfolio companies 7
Rounds per year 2.67
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.12
Exits 1
Key employees Soon

Areas of investment

  • Health Care
  • Therapeutics
  • Alternative Medicine
  • Cannabis
  • Medical

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Ambria Capital:
Typical Co-investors
Ambria Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Ambria Capital:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
GreenGage Capital Illinois, United States, Wilmette
GW Asia Capital -
Ingram Digital Ventures La Vergne, Tennessee, United States
Nanjing Youchuang Jiaye China, Fujian, Zhangzhou
Neurimmune Holding Schlieren, Switzerland, Zurich
Pengpai -
Pivot Ventures -
Progression Fund -
Sixt Rental Cars Bavaria, Germany, Pullach Im Isartal
Solvay Belgium, Brussels, Brussels Hoofdstedelijk Gewest

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

HealingMaps

Health Care
Information Technology
Medical
$1M15 Sep 2022 Miami, Florida, United States

Wonder Sciences

Health Care
$5M01 Jul 2022 Los Angeles, California, United States

Tyson 2.0

Cannabis
Recreation
$9M30 Jun 2022 Chicago, Illinois, United States

Fyllo

Cannabis
Cloud Computing
Cloud Data Services
Compliance
Enterprise Software
Software
$40M08 Nov 2021 Chicago, Illinois, United States

MycroDose Therapeutics

Pharmaceutical
21 Sep 2021 San Diego, California, United States

NanoPsy

Medical
Medical Device
$397K29 Jun 2021 Toronto, Ontario, Canada

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Ambria Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 8
Average round size 9M
Rounds per year 2.67
Peak activity year 2021
Lead investments 0
Follow on index 0.12
Exits 1
Group Appearance index 0.88

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

HealingMaps

Health Care
Information Technology
Medical
$1M15 Sep 2022 Miami, Florida, United States

Wonder Sciences

Health Care
$5M01 Jul 2022 Los Angeles, California, United States

Tyson 2.0

Cannabis
Recreation
$9M30 Jun 2022 Chicago, Illinois, United States

Fyllo

Cannabis
Cloud Computing
Cloud Data Services
Compliance
Enterprise Software
Software
$40M08 Nov 2021 Chicago, Illinois, United States

MycroDose Therapeutics

Pharmaceutical
21 Sep 2021 San Diego, California, United States

NanoPsy

Medical
Medical Device
$397K29 Jun 2021 Toronto, Ontario, Canada
Crunchbase icon

Content report

The following text will be sent to our editors: